(-0.02%) 5 468.14 points
(-0.03%) 39 099 points
(0.26%) 17 763 points
(-0.53%) $80.40
(-4.32%) $2.64
(-0.84%) $2 311.20
(-0.05%) $28.86
(2.27%) $1 008.80
(0.27%) $0.936
(0.69%) $10.68
(0.47%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company\'s discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics...
Stats | |
---|---|
Today's Volume | 304 115 |
Average Volume | 590 069 |
Market Cap | 445.08M |
EPS | $-0.190 ( Q1 | 2024-05-09 ) |
Next earnings date | ( $-0.180 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.94 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00500 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-18 | Love Steven | Buy | 20 000 | Restricted Stock Units |
2024-06-18 | Love Steven | Buy | 40 000 | Stock Option (right to buy) |
2024-06-18 | Higgins John L | Buy | 20 000 | Common Stock |
2024-06-18 | Higgins John L | Buy | 20 000 | Restricted Stock Units |
2024-06-18 | Higgins John L | Buy | 40 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
69.33 |
Last 99 transactions |
Buy: 7 848 926 | Sell: 800 922 |
Volume Correlation
OmniAb, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OmniAb, Inc. Correlation - Currency/Commodity
OmniAb, Inc. Financials
Annual | 2023 |
Revenue: | $34.16M |
Gross Profit: | $14.67M (42.93 %) |
EPS: | $-0.510 |
FY | 2023 |
Revenue: | $34.16M |
Gross Profit: | $14.67M (42.93 %) |
EPS: | $-0.510 |
FY | 2022 |
Revenue: | $59.08M |
Gross Profit: | $42.83M (72.49 %) |
EPS: | $-0.260 |
FY | 2021 |
Revenue: | $34.75M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.235 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
OmniAb, Inc.
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company\'s discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company\'s OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators